Sotorasib (Sotoxen 120mg) Lumakras
INDICATIONS AND USAGE
LUMAKRAS is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
DOSAGE FORMS & STRENGTHS: Sotorasib Tablets: 120 mg.
Manufactured By: Amgen Inc.
generic is Sotorasib (Sotoxen) manufactured by Everest Pharma
LUMAKRAS™ (sotorasib) Sotoxen is an oral treatment for NSCLC that has spread to other parts of the body and has KRAS G12C mutation and Sotorasib (Sotoxen) available generic version in Bangladesh.
Sotoxen (Sotorasib), generic. Lumakras is a prescription medicine used to treat metastatic non-small cell lung cancer.
Sotoxen manufactured by Everest Pharma Ltd. In Bangladesh.
Have to take orally 960 mg (eight 120 mg tablets) orally once daily with or without food.
Tablet | 56’s Pot
Originator : Lumakras by Amgen Inc.
The most common side effects are:
Nausea, vomiting, diarrhea or constipation, muscle/ joint pain, or tiredness.
The above information comes from the Internet. Please consult with doctor for medical advice.